Literature DB >> 17630087

Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activation.

Norio Horiguchi1, Edward J N Ishac, Bin Gao.   

Abstract

UNLABELLED: Liver regeneration is suppressed in alcoholic patients; however, the underlying mechanisms are not fully understood. We examined liver regeneration and signal transducer and activator of transcription 3 (STAT3) activation (an important signal for liver regeneration) in cirrhotic livers from alcoholics, hepatitis C virus (HCV) infection, and alcoholic plus HCV infection. Liver regeneration and STAT3 activation were determined by immunohistochemistry analysis of Ki67 and STAT3 phosphorylation, respectively, in 20 alcoholic cirrhosis, 13 HCV cirrhosis, 13 alcoholic+HCV cirrhosis. Alcoholic or alcoholic plus HCV cirrhotic livers had significantly lower Ki67+ and phospho-STAT3+ (pSTAT3+) hepatocytes and bile duct cells than HCV cirrhotic livers. The pSTAT3 positive staining did not correlate with liver injury (elevation of serum levels of aspartate transaminase [AST] and alkaline phosphatase [ALP]) but correlated positively with cell proliferation (Ki67 positive staining). IN
CONCLUSION: liver regeneration is suppressed in alcoholic cirrhotic livers, which may be partly due to decreased STAT3 activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630087      PMCID: PMC1986734          DOI: 10.1016/j.alcohol.2007.04.008

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  43 in total

1.  Deficient Stat3 DNA-binding is associated with high Pias3 expression and a positive anti-apoptotic balance in human end-stage alcoholic and hepatitis C cirrhosis.

Authors:  Peter Stärkel; Christine De Saeger; Isabelle Leclercq; Alastair Strain; Yves Horsmans
Journal:  J Hepatol       Date:  2005-10       Impact factor: 25.083

2.  Long-term ethanol administration and short- and long-term liver regeneration after partial hepatectomy.

Authors:  H Orrego; I R Crossley; V Saldivia; A Medline; G Varghese; Y Israel
Journal:  J Lab Clin Med       Date:  1981-02

3.  An inhibitor of cyclin-dependent kinase, stress-induced p21Waf-1/Cip-1, mediates hepatocyte mito-inhibition during the evolution of cirrhosis.

Authors:  John G Lunz; Hirokazu Tsuji; Isao Nozaki; Noriko Murase; Anthony J Demetris
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

4.  Expression of cyclin-dependent kinase inhibitor p21 in human liver.

Authors:  G S Crary; J H Albrecht
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

Review 5.  Cytokines, STATs and liver disease.

Authors:  Bin Gao
Journal:  Cell Mol Immunol       Date:  2005-04       Impact factor: 11.530

6.  STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.

Authors:  Won-Il Jeong; Ogyi Park; Svetlana Radaeva; Bin Gao
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

7.  In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats.

Authors:  Zhaoli Sun; Andrew S Klein; Svetlana Radaeva; Feng Hong; Osama El-Assal; Hong-Na Pan; Barbara Jaruga; Sandor Batkai; Sumito Hoshino; Zhigang Tian; George Kunos; Anna Mae Diehl; Bin Gao
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

8.  Chronic ethanol administration to rats decreases receptor-operated mobilization of intracellular ionic calcium in cultured hepatocytes and inhibits 1,4,5-inositol trisphosphate production: relevance to impaired liver regeneration.

Authors:  B H Zhang; B P Hornsfield; G C Farrell
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

9.  Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation.

Authors:  F Y Lee; R H Lu; Y T Tsai; H C Lin; M C Hou; C P Li; T M Liao; L F Lin; S S Wang; S D Lee
Journal:  Scand J Gastroenterol       Date:  1996-05       Impact factor: 2.423

10.  Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms.

Authors:  Sanae Haga; Keita Terui; Hui Qi Zhang; Shin Enosawa; Wataru Ogawa; Hiroshi Inoue; Torayuki Okuyama; Kiyoshi Takeda; Shizuo Akira; Tetsuya Ogino; Kaikobad Irani; Michitaka Ozaki
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

View more
  19 in total

Review 1.  Phosphorylation mechanisms in intensive care medicine.

Authors:  Erica L Martin; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2010-09-04       Impact factor: 17.440

Review 2.  Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

Authors:  Andrew M Miller; Norio Horiguchi; Won-Il Jeong; Svetlana Radaeva; Bin Gao
Journal:  Alcohol Clin Exp Res       Date:  2011-02-01       Impact factor: 3.455

Review 3.  Pathogenesis of alcoholic liver disease: the role of nuclear receptors.

Authors:  Maxwell Afari Gyamfi; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2010-05

4.  Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice.

Authors:  Xue Chen; Kesheng Wang; Arthur I Cederbaum; Yongke Lu
Journal:  Biochem Biophys Res Commun       Date:  2019-03-12       Impact factor: 3.575

Review 5.  Combination therapy: New hope for alcoholic hepatitis?

Authors:  Bin Gao; Vijay H Shah
Journal:  Clin Res Hepatol Gastroenterol       Date:  2015-07-17       Impact factor: 2.947

Review 6.  Signalling pathways in alcohol-induced liver inflammation.

Authors:  Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Hepatol       Date:  2009-03-28       Impact factor: 25.083

Review 7.  Molecular mechanisms of alcoholic fatty liver.

Authors:  Vishnudutt Purohit; Bin Gao; Byoung-Joon Song
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

8.  Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury.

Authors:  Norio Horiguchi; Lei Wang; Partha Mukhopadhyay; Ogyi Park; Won Il Jeong; Fouad Lafdil; Douglas Osei-Hyiaman; Akira Moh; Xin Yuan Fu; Pál Pacher; George Kunos; Bin Gao
Journal:  Gastroenterology       Date:  2008-01-11       Impact factor: 22.682

Review 9.  Interleukin-22 in alcoholic hepatitis and beyond.

Authors:  Xiaogang Xiang; Seonghwan Hwang; Dechun Feng; Vijay H Shah; Bin Gao
Journal:  Hepatol Int       Date:  2020-09-05       Impact factor: 6.047

Review 10.  Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine.

Authors:  Iván M Moya; Georg Halder
Journal:  Nat Rev Mol Cell Biol       Date:  2019-04       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.